Inverse correlation between expression of HLA-B and c-myc in uveal melanoma
- PMID: 9072006
- DOI: 10.1002/(SICI)1096-9896(199701)181:1<75::AID-PATH724>3.0.CO;2-V
Inverse correlation between expression of HLA-B and c-myc in uveal melanoma
Abstract
HLA class I is expressed in 75-85 per cent of uveal melanoma and cytoplasmic c-myc expression has been reported in 78 per cent of uveal melanoma. In skin melanoma, an inverse relationship has been observed between HLA class I expression and c-myc. The purpose of this study was to determine whether a similar correlation occurred between high expression of c-myc and low expression of HLA class I in uveal melanoma. The expression of c-myc, HLA-A, and HLA-B was determined by immunohistochemistry on formalin-fixed and paraffin-embedded sections of 30 uveal melanomas. Cell cultures from four primary uveal melanomas (lines 92-1, MEL 202, OCM-1, and EOM-3) and one uveal melanoma metastasis (line OMM-1) were tested for mRNA levels of c-myc and HLA-A and HLA-B in Northern blot assays. The high level of expression of cytoplasmic c-myc was significantly correlated with low expression of HLA-B (P = 0.03) and vice versa. High expression of HLA-B was significantly correlated with the presence of epithelioid cells (P = 0.004). The inverse correlation observed between c-myc and HLA-B expression is similar to previous observations in cutaneous melanoma. By downregulating HLA-B expression, c-myc may influence the immune response in uveal melanoma. Tumours containing epithelioid cells showed a significantly higher expression of HLA-B than tumours of the spindle cell type.
Similar articles
-
Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1865-72. Invest Ophthalmol Vis Sci. 1997. PMID: 9286277
-
Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.Am J Pathol. 1995 Oct;147(4):1097-104. Am J Pathol. 1995. PMID: 7573354 Free PMC article.
-
Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?Semin Cancer Biol. 1991 Feb;2(1):73-83. Semin Cancer Biol. 1991. PMID: 1912519
-
HLA expression in uveal melanoma: there is no rule without some exception.Hum Immunol. 2002 Jun;63(6):444-51. doi: 10.1016/s0198-8859(02)00389-0. Hum Immunol. 2002. PMID: 12039519 Review.
-
Tebentafusp: First Approval.Drugs. 2022 Apr;82(6):703-710. doi: 10.1007/s40265-022-01704-4. Drugs. 2022. PMID: 35364798 Review.
Cited by
-
c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells.Br J Cancer. 2012 Jun 5;106(12):1980-8. doi: 10.1038/bjc.2012.197. Epub 2012 May 15. Br J Cancer. 2012. PMID: 22588558 Free PMC article.
-
BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.Oncotarget. 2015 Oct 20;6(32):33397-409. doi: 10.18632/oncotarget.5179. Oncotarget. 2015. PMID: 26397223 Free PMC article.
-
The relation between c-myc expression and interferon sensitivity in uveal melanoma.Br J Ophthalmol. 2004 Dec;88(12):1563-7. doi: 10.1136/bjo.2003.033498. Br J Ophthalmol. 2004. PMID: 15548813 Free PMC article.
-
Immune escape mechanisms of intraocular tumors.Prog Retin Eye Res. 2009 Sep;28(5):329-47. doi: 10.1016/j.preteyeres.2009.06.002. Epub 2009 Jun 27. Prog Retin Eye Res. 2009. PMID: 19563908 Free PMC article. Review.
-
Molecular prognostic testing and individualized patient care in uveal melanoma.Am J Ophthalmol. 2009 Dec;148(6):823-9.e1. doi: 10.1016/j.ajo.2009.07.004. Epub 2009 Oct 2. Am J Ophthalmol. 2009. PMID: 19800609 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials